Evolent Health: Citigroup Downgrades to Buy with Lower PT to $6 from $9.5.

viernes, 9 de enero de 2026, 11:02 am ET1 min de lectura
C--
EVH--

Evolent Health: Citigroup Downgrades to Buy with Lower PT to $6 from $9.5.

Evolent Health: Citigroup Downgrades to Buy with Lower PT to $6 from $9.5.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios